Topline results that were recently released from Sydnexis’s phase 3 Study of Atropine for the Reduction of Myopia Progression ...

How much should your bankroll be? The amount of money you’re willing to lose and forget about. This doesn’t mean that you will lose, but it rather serves to maintain the mindset that, if you do lose, ...

NovaBridge subsidiary Visara assigned its exclusive license to Everest Medicines to accelerate the development of potential best-in-class therapy for wet AMD, VIS-101, leveraging Everest Medicines' st ...

Although a time of celebration and togetherness, the holiday season can also be a stressful time, and with the added ...

GLP-1 medications like Ozempic, Zepbound and Wegovy are revolutionizing weight management, but with their growing popularity ...

Nutrition 101 announced the acquisition of Value Feeds with strategic supply contracts from the region's leading dairy ...

Kyverna Therapeutics (KYTX) is rated a strong buy with promising KYV-101 Phase 2 data and near-term catalysts. Read here for ...

S&G PROPERTIES MANAGEMENT, with Lee & Associates' help, acquires a 62K sq. ft. L.A. office building to occupy and upgrade.

Streamline your day, boost client engagement, and communicate smarter with AI. This quick guide gives financial advisors five ...

Absci accelerates ABS-201 in alopecia & endometriosis, targets data by 2027, and refocuses pipeline for value.

India faces a diabetes crisis with 101 million affected, yet insulin use is hampered by myths. Experts urge timely insulin ...

Total income grew by 29.6% in Q3 and 14.5% in the first 9 months of 2025, driven by strong results across investment ...